Prison Officer At JCCC Granted $2M In Assault Settlement
Prison Officer At JCCC Granted $2M In Assault Settlement

Introduction
A financial payout was given to a prison officer at the Jefferson City Correctional Center after an inmate assault left him with serious and lasting disabilities.
Following an incident at JCCC on July 19, the officer and his wife filed a lawsuit against the convict. According to the lawsuit, the inmate's activities caused the officer to be unable to appropriately provide for his wife. According to online court documents, the cop received $1.5 million in damages, while his wife received $500,000 in damages.
According to the lawsuit, the officer informed the inmate at about 8 a.m. to lock down in his cell, but he refused. According to the lawsuit, the convict then pushed the officer down and punched, kicked, and beat him repeatedly and savagely.
The cop suffered serious and lasting head, brain, side, and hip injuries. According to the claim, he was in a coma for six days and was on life support. It was also said that the cop would be unable to work again.
The inmate is also charged with first-degree assault on a special victim. In that matter, no hearing has been scheduled. The convict had been sentenced to 18 years in prison for first-degree assault, robbery, burglary, and armed criminal action. In March 2021, he pled guilty to the counts in Johnson County. He is presently incarcerated in the Potosi Correctional Center.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…